Literature DB >> 11509636

Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4.

S T Smiley1, J A King, W W Hancock.   

Abstract

Extravascular fibrin deposition is an early and persistent hallmark of inflammatory responses. Fibrin is generated from plasma-derived fibrinogen, which escapes the vasculature in response to endothelial cell retraction at sites of inflammation. Our ongoing efforts to define the physiologic functions of extravasated fibrin(ogen) have led to the discovery, reported here, that fibrinogen stimulates macrophage chemokine secretion. Differential mRNA expression analysis and RNase protection assays revealed that macrophage inflammatory protein-1alpha (MIP-1alpha), MIP-1beta, MIP-2, and monocyte chemoattractant protein-1 are fibrinogen inducible in the RAW264.7 mouse macrophage-like cell line, and ELISA confirmed that both RAW264.7 cells and primary murine thioglycolate-elicited peritoneal macrophages up-regulate the secretion of monocyte chemoattractant protein-1 >100-fold upon exposure to fibrinogen. Human U937 and THP-1 precursor-1 (THP-1) monocytic cell lines also secreted chemokines in response to fibrinogen, upon activation with IFN-gamma and differentiation with vitamin D(3), respectively. LPS contamination could not account for our observations, as fibrinogen-induced chemokine secretion was sensitive to heat denaturation and was unaffected by the pharmacologic LPS antagonist polymyxin B. Nevertheless, fibrinogen- and LPS-induced chemokine secretion both apparently required expression of functional Toll-like receptor 4, as each was diminished in macrophages derived from C3H/HeJ mice. Thus, innate responses to fibrinogen and bacterial endotoxin may converge at the evolutionarily conserved Toll-like recognition molecules. Our data suggest that extravascular fibrin(ogen) induces macrophage chemokine expression, thereby promoting immune surveillance at sites of inflammation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11509636     DOI: 10.4049/jimmunol.167.5.2887

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  298 in total

1.  Clots Are Potent Triggers of Inflammatory Cell Gene Expression: Indications for Timely Fibrinolysis.

Authors:  Robert A Campbell; Adriana Vieira-de-Abreu; Jesse W Rowley; Zechariah G Franks; Bhanu Kanth Manne; Matthew T Rondina; Larry W Kraiss; Jennifer J Majersik; Guy A Zimmerman; Andrew S Weyrich
Journal:  Arterioscler Thromb Vasc Biol       Date:  2017-08-03       Impact factor: 8.311

Review 2.  Role of TLR2-dependent inflammation in metastatic progression.

Authors:  Sunhwa Kim; Michael Karin
Journal:  Ann N Y Acad Sci       Date:  2011-01       Impact factor: 5.691

Review 3.  Disseminated intravascular coagulation: old disease, new hope.

Authors:  Cheng Hock Toh; Michael Dennis
Journal:  BMJ       Date:  2003-10-25

4.  Blood-brain barrier pathophysiology in traumatic brain injury.

Authors:  Adam Chodobski; Brian J Zink; Joanna Szmydynger-Chodobska
Journal:  Transl Stroke Res       Date:  2011-12       Impact factor: 6.829

Review 5.  Toll-like receptor signaling: a potential link among rheumatoid arthritis, systemic lupus, and atherosclerosis.

Authors:  QiQuan Huang; Richard M Pope
Journal:  J Leukoc Biol       Date:  2010-05-19       Impact factor: 4.962

6.  Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen.

Authors:  Kris A Steinbrecher; Netanel A Horowitz; Elizabeth A Blevins; Kelley A Barney; Maureen A Shaw; Eleana Harmel-Laws; Fred D Finkelman; Matthew J Flick; Malinda D Pinkerton; Kathryn E Talmage; Keith W Kombrinck; David P Witte; Joseph S Palumbo
Journal:  Cancer Res       Date:  2010-03-16       Impact factor: 12.701

Review 7.  Novel aspects of fibrin(ogen) fragments during inflammation.

Authors:  Carla Jennewein; Nguyen Tran; Patrick Paulus; Peter Ellinghaus; Johannes Andreas Eble; Kai Zacharowski
Journal:  Mol Med       Date:  2011-01-04       Impact factor: 6.354

8.  Combination therapy with VELCADE and tissue plasminogen activator is neuroprotective in aged rats after stroke and targets microRNA-146a and the toll-like receptor signaling pathway.

Authors:  Li Zhang; Michael Chopp; Xianshuang Liu; Hua Teng; Tao Tang; Haifa Kassis; Zheng Gang Zhang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-06-21       Impact factor: 8.311

9.  Inhibition of the cluster of differentiation 14 innate immunity pathway with IAXO-101 improves chronic microelectrode performance.

Authors:  John K Hermann; Madhumitha Ravikumar; Andrew J Shoffstall; Evon S Ereifej; Kyle M Kovach; Jeremy Chang; Arielle Soffer; Chun Wong; Vishnupriya Srivastava; Patrick Smith; Grace Protasiewicz; Jingle Jiang; Stephen M Selkirk; Robert H Miller; Steven Sidik; Nicholas P Ziats; Dawn M Taylor; Jeffrey R Capadona
Journal:  J Neural Eng       Date:  2018-04       Impact factor: 5.379

10.  Gangliosides trigger inflammatory responses via TLR4 in brain glia.

Authors:  Ilo Jou; Jee Hoon Lee; Soo Young Park; Hee Jung Yoon; Eun-Hye Joe; Eun Jung Park
Journal:  Am J Pathol       Date:  2006-05       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.